Trendelenburg As a First-line Intervention in Critically Ill, Sedated, Invasively Mechanically Ventilated, Hypotensive Patients

NCT ID: NCT05209737

Last Updated: 2024-11-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-31

Study Completion Date

2026-10-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A pilot randomized controlled trial to evaluate the efficacy and safety of Trendelenburg position in critically ill patients with hypotension, mainly patients with septic shock and post operative vasoplegia. The main aim is to assess whether Trendelenburg position can improve organ function through a reduction in the need of fluid infusion and dose of vasopressors.

Patients will be screened for participation in the study and eventually randomized based on a balanced randomization scheme (1:1) to Trendelenburg position up to 72 hours after intensive care unit (ICU) admission or Semirecumbent position (standard of care).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Current consensus on circulatory shock management defines shock as a life-threatening, generalized form of acute circulatory failure associated with inadequate tissue perfusion. Recommended interventions to improve perfusion include early hemodynamic stabilization through fluid resuscitation, along with treatment of the cause of shock. If impaired cardiac function results in inadequate cardiac output and tissue hypoperfusion despite fluid therapy, vasopressor agents should be administered.

Nevertheless, fluid overload causes multi-organ edema, such as pulmonary edema or hepatic congestion. Moreover, the negative effects of fluid intravenous administrations were also studied on healthy volunteers during the years. Most of them showed the development of lung injury due to fluid administration.

In addition, vasopressors are also associated with poor outcomes. Described serious adverse effects include organ ischemia, tachyarrhythmias, and atrial fibrillation, leading to organ dysfunction and mortality.

The head-down position, also known as the Trendelenburg position, was originally used by the surgeon Friederich Trendelenburg to improve surgical exposure of pelvic organs. The Trendelenburg position became then a widely popular procedure in managing patients with hypotension and shock. The primary effect of the Trendelenburg position is an increase in cardiac output. Although the short term effect on blood pressure and CO is certain, there is no agreement on its benefit in terms of tissue perfusion and clinical outcome in critically ill hypotensive patients, as nobody has attempted the Trendelenburg position as first line management.

To date, the gold standard position for patients in ICU according to the latest ESICM guidelines to prevent ventilator-associated pneumonia is the semirecumbent position. Experts recommend elevating the head of the patient on the bed to a 20-45 degrees position, preferably \>30 degrees position.

Critically ill patients with hypotension, mainly patients with septic shock and those with post-operative vasoplegia, may be a subgroup of patients, who would benefit from a head-down position if the risks of aspiration pneumonia are minimized. The Trendelenburg position might permit to avoid the deleterious side effects of fluids and vasoconstrictor administration.

The idea is that Trendelenburg position can improve organ function through a reduction in the need of fluid infusion and doses of vasopressors in hypovolemic, hypotensive ICU patients and therefore increase ventilator free days.

The main aim of this trial is to assess if Trendelenburg position can reduce time to severe hypotension resolution.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypotension Shock

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Trendelenburg position

Position: 10-degree Head-down position

Group Type EXPERIMENTAL

Trendelenburg position

Intervention Type PROCEDURE

A 10-degree head-down position will be used in this group

Semirecumbent position

Position: 30-degree Head-up position

Group Type ACTIVE_COMPARATOR

Semirecumbent position

Intervention Type PROCEDURE

A 30-degree head-up position will be used in this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trendelenburg position

A 10-degree head-down position will be used in this group

Intervention Type PROCEDURE

Semirecumbent position

A 30-degree head-up position will be used in this group

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>18 years
* Admitted to the intensive care unit (ICU);
* Invasive mechanical ventilation;
* Pharmacological sedation;
* Mean arterial pressure (MAP)\<65 mmHg or need of fluids infusion or any vasopressor in order to keep MAP \> 65 mmHg
* Ongoing invasive and/or non-invasive arterial blood pressure monitoring
* Central venous line with central venous pressure (CVP) monitoring
* Naso-gastric tube in situ
* Indwelling bladder catheter
* Consent according to local ethical committee rules

Exclusion Criteria

* Body mass index \> 45
* Documented or suspected increased intracranial pressure, based on medical history or actual clinical condition (es. intracranial tumor, cerebral hemorrhage, encephalitis,...);
* Intra-abdominal hypertension \>25 mmHg
* Documented or suspected increased intraocular pressure (any degree of glaucoma)
* Full stomach pyloric incontinence;
* Gastric stasis, defined as aspiration from the NG (nasogastric) tube of fecal, bloody, or green fluid greater than 100 mL upon insertion of the tube or within the preceding hour;
* Ongoing enteral nutrition
* No central line inserted or femoral central line only
* Not sutured known diaphragm lesions
* Known hiatus hernia
* Aortic bifurcation and/or lower extremity arterial stenosis ≥70% combined with stage 3 intermittent claudication (pain at rest)
* Patients who are not able to be investigated with a leg raising test (eg lower extremities fractures, backbone fractures or backbone pain or deformity, and those patients with large cannulas in the femoral vessels)
* Demand of specific postures (eg Trauma, fractures, backbone pain or deformity, patients with large cannulas in the femoral vessels, pronation including first pronation planned within 6 h…)
* Any device which, according to the clinician, makes it unfeasible or unsafe to put patients in the Trendelenburg position (eg Drainage in thoracic cavity)
* Mechanical Circulatory Support;
* (CHD) (Gleen, Fontaine);
* Advanced right ventricular dysfunction or advanced cardiac failure, in which volume overload worsens cardiac function (plateau stage in the Frank-Starling curve);
* Actual upper gastrointestinal bleeding
* Passive leg raising test non-responder
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Negovsky Reanimatology Research Institute

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Valery Likhvantsev, MD

Head of the Research V. Negovsky Reanimatology Research Institute

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vishnevsky Center of Surgery

Moscow, , Russia

Site Status RECRUITING

Demikhov Municipal Clinical Hospital 68

Moscow, , Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Valery Likhvantsev

Role: CONTACT

+79036235982

Levan Berikashvili

Role: CONTACT

+79263308968

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

George Plotnikov, PhD

Role: primary

+79253117509

Roman Kornelyuk, PhD

Role: backup

+79234836510

George Plotnikov, PhD

Role: backup

Roman Kornelyuk, PhD

Role: backup

Valery Komkova, MD

Role: backup

Levan Berikashvili

Role: primary

+79263308968

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Trend

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fluids in Sepsis and Septic Shock
NCT02748382 COMPLETED PHASE2/PHASE3